Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Argentina sticks with COVID-19 lockdown focused in and around Buenos Aires

Fri, 14th Aug 2020 18:43

BUENOS AIRES, Aug 14 (Reuters) - Argentina extended until
Aug. 30 restrictions taken against the coronavirus, President
Alberto Fernandez said on Friday, affirming that the country's
lockdown would continue in its current form in an around capital
city Buenos Aires.

The measures, which are more relaxed in less densely
populated areas, had been scheduled to expire on Sunday.

"The only medicine we have found so far is to limit the
movement of people and the face-to-face meeting of people as
much as possible," Fernandez said.

"The plan worked and it is working, but the risk always
exists."

Argentina has had 276,072 confirmed cases of COVID-19,
5,428 of which have been fatal.

The country's lockdown began on March 20.

Argentina and Mexico will produce the AstraZeneca
COVID-19 vaccine for most of Latin America. Its rollout is
expected in the first quarter, Fernandez said.

(Reporting by Eliana Raszewski; Writing by Hugh Bronstein;
Editing by Richard Chang)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.